This study aimed to investigate whether the biomarkers GFAP, NfL, and VEGF-recently considered important guides for better understanding the pathophysiology of MS-also serve as indicators of clinical progression in MS.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Expanded Disability Status Scale (EDSS)
Timeframe: Baseline
Standardized Mini-Mental Test
Timeframe: Baseline
Symbol Digit Modalities Test
Timeframe: Baseline
Multiple Sclerosis Impact Scale (MSIS-29)
Timeframe: Baseline
Glial Fibrillary Acidic Protein (GFAP)
Timeframe: Baseline
Neurofilament Light Chain (NfL)
Timeframe: Baseline
Vascular Endothelial Growth Factor (VEGF)
Timeframe: Baseline